As a general rule, the receipt of a manuscript will be acknowledged within 2 weeks of submission; authors will be provided with a manuscript reference number for future correspondence. If an acknowledgment is not received in a reasonable period of time, the author should contact the Editorial Office.
Submissions are reviewed by the Editorial Office to ensure that it contains all parts. Submissions will be rejected if the author has not supplied all the material and documents as outlined in these author instructions. Manuscripts are then reviewed by the Editors, who make an initial assessment. If the manuscript does not appear to be of sufficient merit or is not appropriate for the Journal, the manuscript will be rejected without review. Rejected manuscripts will not be returned to authors unless requested. All other manuscripts are sent to 2 or more expert consultants for double-blind peer review. Authors will usually be notified within 12 weeks of the initial acknowledgment of whether the manuscript is accepted for publication, rejected, or subject to revision before acceptance. However, do note that delays are sometimes unavoidable.
IJGII has a specific process for handling submissions by members of the editorial board to ensure an impartial review, treating the editorial board member as any other author, with no access to the internal editorial process for that submission.
Editors who make final decisions about manuscripts must have no personal, professional, or financial involvement in any of the issues they might judge. Other members of the editorial staff, if they participate in editorial decisions, must provide editors with a current description of their financial interests (as they might relate to editorial judgments) and recuse themselves from any decisions in which a conflict of interest exists. Editorial staff must not use information gained through working with manuscripts for private gain. Editors should publish regular disclosure statements about potential conflicts of interests related to the commitments of journal staff. IJGII complies with the Guidelines of the International Committee of Medical Journal Editors on editorial conflict of interest (http://www.icmje.org/#conflicts).
Appeals of a rejection decision are only successful in a handful of cases and usually only when you can provide strong evidence or new data that can respond to and alleviate the concerns of the editor and reviewers. As appeals are matters of journal policy they are given lower priority than new submissions and may take at least several weeks, if not longer, to resolve. Appeals must be rational arguments not emotional ones so be sure you have enough evidence before trying to change the editor's mind.
If you do decide to go ahead with an appeal letter you should:
Clearly explain why you disagree with the decision and provide any new information that you would like the editors to take into consideration. This should not be a repetition of what you have included in your original submission or cover letter.
If the editors or reviewers have highlighted shortcomings with your paper that you think you can address please indicate how you would do this, such as providing further data.
Include a point-by-point response to any reviewer comments.
Provide any evidence to support your opinion when you believe a reviewer has made technical errors in their assessment of your manuscript or has been biased.
Editors will consider one appeal per article and all decisions on appeals are final. The timely review and decision-making process for new submissions will take precedence over appeals
Xudong Liu , Zhengqiang Yang , Shun He , and Guiqi Wang
Int J Gastrointest Interv 2021; 10(2): 42-48
Int J Gastrointest Interv 2021; 10(2): 59-62
Charles Y. Kim and Ji Hoon Shin
Int J Gastrointest Interv 2021; 10(2): 54-58
Int J Gastrointest Interv 2021; 10(3): 96-100
Pankaj N. Desai , Chintan N. Patel , Mayank V. Kabrawala , Subhash K. Nandwani , Rajiv M. Mehta , Parika Kalra , Ritesh Prajapati , Nisharg Patel , and Krishna K. Parekh
Int J Gastrointest Interv 2021; 10(2): 84-88
Partha Mandal , Barrett P. O'Donnell , Eric Reuben Smith , Osamah Al-Bayati , Adam Khalil , Serena Jen , Mario Vela , and Jorge Lopera
Int J Gastrointest Interv 2022; 11(1): 18-23
© The Society of Gastrointestinal Intervention. Powered by INFOrang Co., Ltd.